Business Description
Item 9 Labs Corp
NAICS : 325412
SIC : 2834
ISIN : US46564C1045
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.65 | |||||
Debt-to-EBITDA | -1.73 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -2.03 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 41.6 | |||||
3-Year EBITDA Growth Rate | -18.1 | |||||
3-Year EPS without NRI Growth Rate | -52.5 | |||||
3-Year FCF Growth Rate | 17.5 | |||||
3-Year Book Growth Rate | 75.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 27.96 | |||||
9-Day RSI | 34.77 | |||||
14-Day RSI | 37.88 | |||||
6-1 Month Momentum % | -95.73 | |||||
12-1 Month Momentum % | -99.88 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.06 | |||||
Quick Ratio | 0.02 | |||||
Days Inventory | 96.54 | |||||
Days Sales Outstanding | 12.4 | |||||
Days Payable | 239.21 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.3 | |||||
Shareholder Yield % | -73873 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 49.8 | |||||
Operating Margin % | -51.01 | |||||
Net Margin % | -157.62 | |||||
FCF Margin % | -13.19 | |||||
ROE % | -49.87 | |||||
ROA % | -27.12 | |||||
ROIC % | -7.09 | |||||
ROC (Joel Greenblatt) % | -87.54 | |||||
ROCE % | -31.9 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -1.57 | |||||
EV-to-EBITDA | -1.72 | |||||
EV-to-Revenue | 1.73 | |||||
EV-to-FCF | -13.13 | |||||
Earnings Yield (Greenblatt) % | -63.69 | |||||
FCF Yield % | 3.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:INLB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Item 9 Labs Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 19.69 | ||
EPS (TTM) ($) | -0.32 | ||
Beta | 0.27 | ||
Volatility % | 74.38 | ||
14-Day RSI | 37.88 | ||
14-Day ATR ($) | 0.000011 | ||
20-Day SMA ($) | 0.0001 | ||
12-1 Month Momentum % | -99.88 | ||
52-Week Range ($) | 0.0001 - 0.095 | ||
Shares Outstanding (Mil) | 102.36 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Item 9 Labs Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Item 9 Labs Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Item 9 Labs Corp Frequently Asked Questions
What is Item 9 Labs Corp(INLB)'s stock price today?
When is next earnings date of Item 9 Labs Corp(INLB)?
Does Item 9 Labs Corp(INLB) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |